Mode
Text Size
Log in / Sign up

Familial combined hyperlipidemia

Part of Hyperlipidemia

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Hyperlipidemia

Related studies from across the Hyperlipidemia family.

Pharmacist-led medication therapy management improves adherence and glycemic control in a patient with complex T2DM
Rheumatology Sys. Review
Pharmacist-led medication therapy management improves adherence and glycemic control in a patient with complex T2DM Pharmacist-led care improves blood sugar for woman with long-term diabetes
This case report describes a single patient with type 2 diabetes who received pharmacist-led medication therapy management. The intervention…
A pharmacist-led review helped a woman with a 30-year history of Type 2 Diabetes significantly improve her medication adherence and blood su…
Pitaya by-products show antioxidant, anti-inflammatory, hypolipidemic, and hypoglycemic potential in systematic review
Nutrition & Obesity Medicine Sys. Review
Pitaya by-products show antioxidant, anti-inflammatory, hypolipidemic, and hypoglycemic potential in systematic review Pitaya By-products Show Potential for Managing Blood Sugar and Cholesterol
This systematic review of pitaya (Selenicereus spp.) by-products finds they are rich in bioactive compounds and exhibit antioxidant, anti-in…
Discarded parts of the pitaya fruit, like seeds and peels, contain compounds that may help manage high blood sugar and cholesterol levels.
Heart-healthy dietary interventions do not significantly alter serum Lp(a) concentrations in children
Cardiology RCT
Heart-healthy dietary interventions do not significantly alter serum Lp(a) concentrations in children Heart-Healthy Diet Does Not Lower Lp(a) in Children
This RCT of 1062 healthy children found that median serum Lp(a) increased from infancy until age 13. While a heart-healthy diet was tested, …
A heart-healthy diet barely budges Lp(a) in kids. The real surprise? Lp(a) levels track strongly from infancy.
Cerivastatin best for total cholesterol, simvastatin for LDL-C in DKD with hyperlipidemia
Diabetes & Endocrinology Meta-analysis
Cerivastatin best for total cholesterol, simvastatin for LDL-C in DKD with hyperlipidemia Lipid-Lowering Drugs Show Different Benefits for Kidney Disease
A network meta-analysis of 20 RCTs in patients with diabetic kidney disease and hyperlipidemia found that cerivastatin most effectively redu…
A review of 20 trials found that different statins and fenofibrate have unique effects on cholesterol, kidney markers, and heart risks in di…
Narrative review on PCSK9 inhibitors for familial hypercholesterolemia
Drug Pipeline Sys. Review
Narrative review on PCSK9 inhibitors for familial hypercholesterolemia Review explores PCSK9 inhibitors for familial hypercholesterolemia
This narrative review synthesizes evidence on PCSK9 inhibitors, including evolocumab, for familial hypercholesterolemia. The authors discuss…
This review looks at PCSK9 inhibitors like evolocumab for people with familial hypercholesterolemia. It discusses how these drugs work and t…
Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman
Ophthalmology Sys. Review
Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman Rare heart attack possible after fluorescein angiography in older adults with heart disease
This case report and review of the literature describes a 76-year-old woman with hypertension, hyperlipidemia, and type 2 diabetes mellitus …
A 76-year-old woman with heart disease had a heart attack shortly after a dye test, highlighting rare risks.
FDA Approves Crestor (rosuvastatin) for Cardiovascular Risk Reduction in Adults
Cardiology FDA Approval
FDA Approves Crestor (rosuvastatin) for Cardiovascular Risk Reduction in Adults FDA approves Crestor to prevent heart attacks and strokes in certain adults.
FDA approved Crestor (rosuvastatin) to reduce risk of major adverse cardiovascular events in adults without established coronary heart disea…
The FDA approved Crestor (rosuvastatin) to reduce the risk of heart attack, stroke, and related events in adults without heart disease but w…
Pitavastatin lowers LDL and MACE risk in people with HIV on stable antiretroviral therapy
Infectious Disease RCT
Pitavastatin lowers LDL and MACE risk in people with HIV on stable antiretroviral therapy This cholesterol drug cuts heart risk for people with HIV
This secondary analysis of a phase 3 trial examined pitavastatin versus placebo in people with HIV aged 40 to 75 years on stable antiretrovi…
A large trial found that a daily statin cut heart risk by more than a third in people with HIV, even when their cholesterol looked fine.
Exploratory analysis of RYGB and SG shows variable LDL cholesterol response in patients with obesity and high LDL cholesterol
Nutrition & Obesity Medicine RCT
Exploratory analysis of RYGB and SG shows variable LDL cholesterol response in patients with obesity and high LDL cholesterol Two bariatric surgeries lower cholesterol through completely different biological paths
This exploratory analysis of a randomized clinical trial (BASALTO) evaluated 30 patients with obesity and high LDL cholesterol undergoing Ro…
New research shows that two popular weight loss surgeries lower bad cholesterol in very different ways that could change how doctors pick a …
Vegetarianism associated with altered lipid profiles in UK Biobank participants
Nutrition & Obesity Medicine Cohort
Vegetarianism associated with altered lipid profiles in UK Biobank participants Vegetarian diets lower cholesterol in UK Biobank participants
This cross-sectional study of UK Biobank participants found that vegetarianism was associated with reduced total, LDL, and HDL cholesterol b…
Vegetarian diets were linked to lower cholesterol levels in a large UK study. This finding applies to people of European, Asian, and African…
Essential phospholipids reduced hepatic steatosis and improved HbA1c in patients with MASLD and type 2 diabetes over 6 months
Diabetes & Endocrinology RCT
Essential phospholipids reduced hepatic steatosis and improved HbA1c in patients with MASLD and type 2 diabetes over 6 months Essential Phospholipids Reduce Liver Fat In Six Months
This randomised, placebo-controlled phase 4 trial enrolled 193 patients with metabolic dysfunction-associated steatotic liver disease and ty…
Essential phospholipids may lower liver fat and improve energy levels for people with fatty liver disease and diabetes within just six month…
Surgical treatment for gouty tophi wounds associated with high healing rates in retrospective study
Orthopedics & Sports Medicine Cohort
Surgical treatment for gouty tophi wounds associated with high healing rates in retrospective study Surgery may help heal gouty tophi wounds
This retrospective cohort study of 130 patients with gouty tophi wounds in China observed high wound healing rates following surgical interv…
A small study shows that surgical treatment, including wound cleaning and vacuum drainage, helped most patients with gouty tophi wounds heal…